Host cell proteins (HCPs) are an unavoidable byproduct in the production of biopharmaceuticals, originating from the cells used to express recombinant proteins. While these proteins may be harmless to the cell cultures that produce them, they can pose a significant risk if they persist in the final drug product. To ensure patient safety and product […]